Jeanne Bolger

Jeanne Bolger is an experienced biopharma senior executive with extensive business development and investment expertise over her 35 years in the pharmaceutical sector. She served on the board of over a dozen life sciences companies during her 10 years as Vice President of Venture Investing at Johnson & Johnson Innovation-JJDC.
Dr. Bolger’s drug development and commercial expertise spans numerous therapeutic fields, including oncology, neurology, psychiatry, respiratory, immunology, infectious disease and vaccines, and cell and gene therapy. She is a Non-Executive Board Director of Life Healthcare. She is also the Chair of the Board at ExeVir and at Astrivax. Dr. Bolger holds an MB BCh in Medicine from University College Dublin. She has been a member of the Sapreme Board of Directors since July 2023.